IP Verse

Modernatx competitive analysis

Latest oppositions filed by Modernatx

Explore patent oppositions filed by Modernatx against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 2, 2026
Patent NumberTitleApplicantOpposition Date
EP4108769
A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow FiltrationCUREVAC MANUFACTURINGMay 20, 2026
EP4226941
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINEJul 15, 2025
EP4241767
Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAApr 29, 2025
EP2958588
Combination Of Vaccination And Inhibition Of The Pd-1 PathwayCUREVACMay 22, 2018
EP2279254
Novel Lipid Formulations For Nucleic Acid DeliveryARBUTUS BIOPHARMAApr 5, 2018

Latest patents of Modernatx opposed by its competitors

Explore Modernatx's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 2, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3350333
Aug 6, 2025Polynucleotides Containing A Stabilizing Tail Region1
EP3394030
Feb 12, 2025Compounds And Compositions For Intracellular Delivery Of Agents1
EP3595727
Nov 27, 2024Lipid Nanoparticle Formulation1
EP4108671
Nov 20, 2024Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof6
EP3981437
Oct 9, 2024Nucleic Acid Vaccines4
EP4023249
Oct 9, 2024Nucleic Acid Vaccines3
EP3853305
Oct 2, 2024High-Purity Peg Lipids And Uses Thereof6
EP3431485
Sep 4, 2024Engineered Nucleic Acids And Methods Of Use Thereof3
EP3917503
May 8, 2024Methods Of Preparing Lipid Nanoparticles1
EP3359670
Feb 14, 2024Methods For Therapeutic Administration Of Messenger Ribonucleic Acid Drugs1

Latest PTAB cases involving Modernatx

Discover the latest PTAB cases involving Modernatx, highlighting their recent legal challenges and patent disputes.

Last updated on: Jul 1, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Modernatx

IPR2023-01358Aug 28, 2023PFIZERMODERNAFinal Written Decision - Appealed
IPR2023-01358Aug 28, 2023PFIZERMODERNATXFinal Written Decision - Appealed
IPR2023-01359Aug 28, 2023BIONTECHMODERNAFinal Written Decision - Appealed
IPR2023-01359Aug 28, 2023BIONTECHMODERNATXFinal Written Decision - Appealed
IPR2017-02194Sep 29, 2017MODERNACUREVACFinal Written Decision
IPR2017-02194Sep 29, 2017MODERNATXCUREVACFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Modernatx with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 2, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MODERNATX3 - 12
ARBUTUS BIOPHARMA - 8 - 3
BIONTECH31101 -
CUREVAC - 72 - 1